125 related articles for article (PubMed ID: 7190409)
1. [Studies in animal experiments on determination of blood and organ levels of o-(beta-hydroxyethyl)-rutosides (HR) after i.p. administration (author's transl)].
Reinartz G; Wurst F
Arzneimittelforschung; 1980; 30(4):657-9. PubMed ID: 7190409
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
[TBL] [Abstract][Full Text] [Related]
3. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
Gábor M
Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
[TBL] [Abstract][Full Text] [Related]
4. [Reduction of radiation-induced late effects on vascular connective tissue of the skin (mouse paw) by o-(beta-hydroxyethyl)-rutoside].
Fritz-Niggli H; Fröhlich E
Rofo; 1979 May; 130(5):601-8. PubMed ID: 155632
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
van Acker SA; Voest EE; Beems DB; Madhuizen HT; de Jong J; Bast A; van der Vijgh WJ
Cancer Res; 1993 Oct; 53(19):4603-7. PubMed ID: 8402634
[TBL] [Abstract][Full Text] [Related]
6. The effect of O-(beta-hydroxyethyl)-rutosides on function and structure of the ganglion cells.
Blasius W; Leusser K; Merker G
Arzneimittelforschung; 1976; 26(9):1645-50. PubMed ID: 1036693
[TBL] [Abstract][Full Text] [Related]
7. [Reduction of radiation-induced early skin damage (mouse foot) by O-(beta-hydroxyethyl)-rutoside (author's transl)].
Fritz-Niggli H; Fröhlich E
Rofo; 1980 Sep; 133(3):316-21. PubMed ID: 6451559
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
Kienzler JL; Sallin D; Schifflers MH; Ghika A
Eur J Clin Pharmacol; 2002 Sep; 58(6):395-402. PubMed ID: 12242598
[TBL] [Abstract][Full Text] [Related]
9. The metabolism and excretion of 7-mono-0-(beta-hydroxyethyl) rutoside in the dog.
Hackett AM; Griffiths LA
Eur J Drug Metab Pharmacokinet; 1979; 4(4):207-12. PubMed ID: 535600
[TBL] [Abstract][Full Text] [Related]
10. [Chromatographic studies of four water-soluble rutosides].
Geissler VG
Arzneimittelforschung; 1975 Apr; 25(4):511-6. PubMed ID: 1174068
[TBL] [Abstract][Full Text] [Related]
11. [Histochemical and ultrastructural studies on the anti-edema and radiation-protective effects of 0-(beta-hydroxyethyl)-rutosides in the rat brain after single-dose irradiation. 1. Electron microscopy study of terminal blood circulation].
Thiel HJ; Hammersen F; Sauer R
Strahlenther Onkol; 1988 Sep; 164(9):544-52. PubMed ID: 3175854
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats.
Gulati OP; Nordmann H; Aellig A; Maignan MF; McGinness J
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):323-34. PubMed ID: 4004421
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
[TBL] [Abstract][Full Text] [Related]
14. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
Stegmann W; Hubner K; Deichmann B; Muller B
Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of O-(beta-hydroxyethyl)-rutosides in serum by high-performance liquid chromatography.
Kuhnz W; Zech K; Lupp R; Jung G; Voelter W; Matzkies F
J Chromatogr; 1983 Feb; 272(2):333-40. PubMed ID: 6833430
[TBL] [Abstract][Full Text] [Related]
17. [Histochemical and ultrastructural studies on anti-edematous and radiation-protective action of 0-(beta-hydroxyethyl)-rutosides on the rat brain after single irradiation. 2. Histochemical study on carbohydrate metabolism and acid phosphatase activation].
Thiel HJ; Lierse W; Lehmann FM; Sauer R
Strahlenther Onkol; 1988 Nov; 164(11):662-73. PubMed ID: 3201383
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice.
Abou El Hassan MA; Kedde MA; Zwiers UT; Tourn E; Haenen GR; Bast A; van der Vijgh WJ
Cancer Chemother Pharmacol; 2003 Nov; 52(5):371-6. PubMed ID: 12898182
[TBL] [Abstract][Full Text] [Related]
19. [Effect ofO-(beta-hydroxyethyl)rutoside on intestinal tract cells following partial body irradiation].
Oberhausen H
Arzneimittelforschung; 1975 Jan; 25(1):101-5. PubMed ID: 1173762
[TBL] [Abstract][Full Text] [Related]
20. The disposition and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl)rutoside and 7-mono-O-(beta-hydroxyethyl)rutoside in the mouse.
Hackett AM; Griffiths LA
Xenobiotica; 1977 Oct; 7(10):641-51. PubMed ID: 910465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
